Yeah, the recent move up into 3-4 cents has been great! Still just a fraction of RXMD's true value, but you have to start somewhere, and January's revenue figures should provide another bump upwards. Wouldn't surprise me if we touch 5 cents at that point.
The additional exposure since RXMD moved to OTCQB has brought a lot of new eyes to the stock, and that's only going to continue as RXMD meets more and more of their goals. And once RXMD has two years of audited financials complete (which should happen in Q1) and institutional investors take an interest... wow! The sky's the limit!
Facts! Accept no substitutes! :D
Please note: CAPS, BOLD, & DOUBLE-BOLD text are no substitute for facts, & fancy COLORS are no replacement for logic & a convincing argument.